What medication is recommended to treat seizures in a pregnant woman undergoing termination, ensuring safety for both mother and fetus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seizure Management During Pregnancy Termination

For seizures occurring during pregnancy termination, benzodiazepines are the first-line treatment, followed by levetiracetam or phenytoin as second-line agents, with valproate reserved only as a last resort if other medications fail. 1

First-Line Treatment: Benzodiazepines

  • Intravenous benzodiazepines remain the drugs of choice for acute seizure management in pregnancy, including during termination procedures 1, 2
  • Benzodiazepines provide rapid seizure control with established safety profiles in pregnancy 2
  • This recommendation applies regardless of whether the pregnancy is continuing or being terminated, as maternal seizure control is the immediate priority 1

Second-Line Agents

Levetiracetam (Preferred)

  • Levetiracetam is the most suitable second-line agent due to its favorable safety profile and lack of significant teratogenic effects 1, 3
  • Levetiracetam has consistently demonstrated the lowest teratogenic potential among antiepileptic drugs 3, 4
  • Standard dosing of 30 mg/kg IV can be administered if benzodiazepines fail to control seizures 5

Phenytoin/Fosphenytoin (Alternative Second-Line)

  • Phenytoin or fosphenytoin represents an acceptable alternative second-line option with extensive historical use in pregnancy 1, 2
  • Load with 20 mg/kg IV of phenytoin equivalents at appropriate infusion rates 5
  • Monitor for hypotension, which occurs more commonly with phenytoin than with levetiracetam 5

Valproate: Use Only as Last Resort

  • Valproate should be avoided, particularly in first-trimester terminations, and used only if all other antiseizure medications have failed 1, 3
  • Valproate is a known teratogen causing neural tube defects and major congenital malformations, and is absolutely contraindicated in females of childbearing potential under normal circumstances 6
  • Even during termination procedures, valproate carries risks to the woman herself and should be reserved for refractory cases 1
  • If valproate must be used, it should be administered only after benzodiazepines, levetiracetam, and phenytoin have all failed 1

Refractory Seizures/Status Epilepticus

  • For refractory status epilepticus, anesthetic drugs are required, with propofol and midazolam as preferred agents 1
  • In extreme cases where general anesthetics fail, termination of pregnancy via delivery or abortion may be necessary to save the mother's life 1
  • A multidisciplinary team approach is essential for managing severe seizures during pregnancy or termination 1

Critical Timing Considerations

  • The first trimester represents the highest risk period for drug-induced teratogenicity due to organogenesis 6
  • However, during an active termination procedure, maternal seizure control takes absolute priority over fetal considerations 1, 2
  • Uncontrolled seizures pose greater immediate risk to the mother than antiseizure medication exposure 2, 7

Common Pitfalls to Avoid

  • Do not delay treatment due to concerns about medication effects during termination - rapid seizure control is paramount for maternal safety 1, 2
  • Do not use magnesium sulfate for non-eclamptic seizures - it lacks true anticonvulsant properties and is specific to eclampsia management 2
  • Do not withhold phenytoin or levetiracetam due to pregnancy concerns - these medications are significantly safer than uncontrolled seizures 1, 7

References

Research

Lamotrigine use in pregnancy.

Expert opinion on pharmacotherapy, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Use in Pregnancy: Contraindications and Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.